Company Info
| Phone: | (510) 742-3400 |
| Year Established: | 2002 |
| Ticker: | RVNC |
| Exchange: | NASDAQ |
Contacts
| Primary: | Mark J. Foley CEO |
| Other: | Tobin Schilke CFO Dustin Sjuts President Dwight Moxie General Counsel David A. Hollander, M.D., M.B.A. CMO Erica Jordan CCO, Aesthetics |
Company Description
Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator product, DaxibotulinumtoxinA for Injection.
